PLC

Headquartered in Milford, Massachusetts, PLC Systems Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. PLC's newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy(CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard's effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA.